Bio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading at a discount. The Rs 52 crore IPO, which saw overall subscription of 2.26 times, aims to fund loan repayment and manufacturing expansion. Despite selective institutional interest, investor caution prevails due to broader market volatility.